Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Brenda Ginos"'
Autor:
Blake T. Langlais, Mrinal M. Gounder, Ethan Basch, M. Petersen, Gary K. Schwartz, Narre Heon, Michelle R. Mahoney, Alexander J. Zoroufy, Amylou C. Dueck, Lauren J. Rogak, Gita Thanarajasingam, Brenda Ginos, Gina L. Mazza
Publikováno v:
Quality of Life Research. 31:1069-1080
Purpose Missing scores complicate analysis of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) because patients with and without missing scores may systematically differ. We focus on optimal anal
Autor:
Fang-Shu Ou, Tsung Teh Wu, Brenda Ginos, Harry H. Yoon, Timothy F. Drevyanko, Steven R. Alberts, Maged F. Khalil, Gamini S. Soori, Robert J. Behrens, Dennis A. Wigle, Stephen J. Ko, Daniel A. Nikcevich, Robert C. Miller, George P. Kim, Qian Shi, James L. Leenstra, Patrick J. Peller, Robert P. Sticca, Erica N. Heying, Bassam I. Mattar
Publikováno v:
Eur J Cancer
Aim report primary results from the first multicentre randomised trial evaluating induction chemotherapy prior to trimodality therapy in patients with oesophageal or gastro-oesophageal junction adenocarcinoma. Notably, recent data from a single-insti
Autor:
Ethan Basch, Deborah Schrag, Sydney Henson, Jennifer Jansen, Brenda Ginos, Angela M. Stover, Philip Carr, Patricia A. Spears, Mattias Jonsson, Allison M. Deal, Antonia V. Bennett, Gita Thanarajasingam, Lauren J. Rogak, Bryce B. Reeve, Claire Snyder, Deborah Bruner, David Cella, Lisa A. Kottschade, Jane Perlmutter, Cindy Geoghegan, Cleo A. Samuel-Ryals, Barbara Given, Gina L. Mazza, Robert Miller, Jon F. Strasser, Dylan M. Zylla, Anna Weiss, Victoria S. Blinder, Amylou C. Dueck
Publikováno v:
JAMA
IMPORTANCE: Electronic systems that facilitate patient-reported outcome (PRO) surveys for patients with cancer may detect symptoms early and prompt clinicians to intervene. OBJECTIVE: To evaluate whether electronic symptom monitoring during cancer tr
Autor:
Gita N. Mody, Marjory Charlot, Ethan Basch, Deborah Watkins Bruner, Allison M. Deal, Arlene E. Chung, Claire F. Snyder, Philip M Carr, Antonia V. Bennett, Jennifer Jansen, Lisa A. Kottschade, Lauren J. Rogak, Mattias Jonsson, Anna Weiss, Amylou C. Dueck, Bryce B. Reeve, Deborah Schrag, Angela M. Stover, Brenda Ginos, Sydney Henson, Gita Thanarajasingam, Patricia A. Spears
Publikováno v:
JCO Clin Cancer Inform
PURPOSE There is increasing interest in implementing digital systems for remote monitoring of patients’ symptoms during routine oncology practice. Information is limited about the clinical utility and user perceptions of these systems. METHODS PRO-
Autor:
Joselle Cook, Kah Whye Whye Peng, Thomas E. Witzig, Stephen M Broski, Jose Caetano Villasboas, Jonas Paludo, Mrinal M Patnaik, vincent Vincent rajkumar, Angela Dispenzieri, Nelson Leung, Francis Buadi, Nora Nora Bennani, Stephen M. Ansell, Lianwen Zhang, Nandakumar Packiriswamy, Baskar Balakrishnan, Bethany Brunton, Marissa Giers, Brenda Ginos, Amylou C. Dueck, Susan Geyer, Morie A Gertz, Rahma Warsame, Ronald S. Go, Suzanne R Hayman, David Dingli, Shaji K Kumar, P. Leif Bergsagel, Javier Munoz, Wilson I Gonsalves, Taxiarchis V. Kourelis, Eli Muchtar, Prashant Kapoor, Robert A Kyle, Yi Lin, Mustaqeem Siddiqui, Amie Fonder, Miriam Hobbs, Yi Lisa Hwa, Shruthi Naik, Stephen J Russell, Martha Q Lacy
Publikováno v:
Blood Advances.
Clinical success with intravenous (IV) oncolytic virotherapy (OV) has to date been anecdotal. Here, we conducted a phase 1 clinical trial of systemic OV therapy and investigated the mechanisms of action in responding T-cell lymphoma (TCL) patients. A
Autor:
Brenda Ginos, Gita Thanarajasingam, Gina L. Mazza, Patricia A. Ganz, Ethan Basch, Narre Heon, Blake T. Langlais, Gisela Schwab, Lauren J. Rogak, Amylou C. Dueck, Howard I. Scher
Publikováno v:
Journal of pain and symptom management, vol 63, iss 2
J Pain Symptom Manage
J Pain Symptom Manage
Context Summarizing longitudinal symptomatic adverse events during clinical trials is necessary for understanding treatment tolerability. The Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) provides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f841fef2db0e82873a951bc7eefd89
https://escholarship.org/uc/item/1d8536cm
https://escholarship.org/uc/item/1d8536cm
Autor:
Gina L, Mazza, Molly M, Petersen, Brenda, Ginos, Blake T, Langlais, Narre, Heon, Mrinal M, Gounder, Michelle R, Mahoney, Alexander J, Zoroufy, Gary K, Schwartz, Lauren J, Rogak, Gita, Thanarajasingam, Ethan, Basch, Amylou C, Dueck
Publikováno v:
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 31(4)
Missing scores complicate analysis of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) because patients with and without missing scores may systematically differ. We focus on optimal analysis met
Autor:
Daniel L. Price, Ashish V. Chintakuntlawar, Samir H. Patel, Joaquin J. Garcia, Michelle A. Neben-Wittich, Yolanda I. Garces, Daniel J. Ma, Brenda Ginos, Kerry D. Olsen, Darlene E. Graner, Robert L. Foote, Robert C. Miller, Satomi Shiraishi, Kathryn M. Van Abel, Michael L. Hinni, Nathan R. Foster, Katharine A. Price, Jeffrey R. Janus, Mark R. Waddle, Eric J. Moore, Jan L. Kasperbauer
Publikováno v:
Journal of Clinical Oncology. 37:1909-1918
PURPOSE The purpose of this study was to determine if dose de-escalation from 60 to 66 Gy to 30 to 36 Gy of adjuvant radiotherapy (RT) for selected patients with human papillomavirus–associated oropharyngeal squamous cell carcinoma could maintain h
Autor:
Gita N. Mody, Arlene E. Chung, Deborah Schrag, Amylou C. Dueck, Angela M. Stover, Mian Wang, Angela B. Smith, Antonia V. Bennett, Mattias Jonsson, Jennifer Jansen, Alison Deal, Sydney Henson, Brenda Ginos, William A. Wood, Bellinda L King-Kallimanis, Ethan Basch
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 162
Objectives Patients with lung cancer have high symptom burden and diminished quality of life. Electronic patient-reported outcome (PRO) platforms deliver repeated longitudinal surveys via web or telephone to patients and alert clinicians about concer
Autor:
Angela Dispenzieri, David Dingli, Rahma Warsame, Eli Muchtar, Morie A. Gertz, Wilson I. Gonsalves, Stephen J. Russell, Yi Lin, Mustagueem Siddiqui, Stephen M. Broski, Suzanne R. Hayman, Marissa Giers, Shaji Kumar, Thomas E. Witzig, Amie Fonder, Taxiarchis Kourelis, S. Vincent Rajkumar, Susan Geyer, Mrnal S. Patnaik, Lianwen Zhang, Ronald S. Go, Amylou C. Dueck, Robert A. Kyle, John A. Lust, Joselle Cook, Kah-Whye Peng, Nandakumar Packiriswamy, Prashant Kapoor, Francis K. Buadi, Leif Bergsagel, Lisa Hwa, Brenda Ginos, Miriam Hobbs, Martha Q. Lacy, Beth Brunton, Nelson Leung
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S416-S417
Context This is the first in human Phase 1 dose escalation trial of oncolytic Vesicular Stomatitis Virus (VSV) incorporating interferon beta and sodium iodine symporter transgenes (VSV-IFNβ-NIS) to be administered intravenously in patients with rela